Small Business Resources, Business Advice and Forms from AllBusiness.com

NICE endorses scheme for NHS to only pay for drugs that work.(Janssen-Cilag)(National Institute...

By Murphy, Marina
Publication: Chemistry and Industry
Date: Monday, June 11 2007

Analysts have welcomed what is the first of its kind endorsement by UK health watchdog National Institute for Health and Clinical Excellence (NICE) of a scheme that would see manufacturers refund the NHS if a patient did not respond to treatment.

The scheme, which was proposed by drug maker Janssen-Cilag, would mean that multiple myeloma patients in Wales and England would get Velcade on the NHS. But the NHS would pay for drug, which costs about 18 000 [pounds sterling] per patient, only if it works.

'The agreement offers the prospect of a win-win situation f

In addition, make sure to read these premium articles also available with your free trial: